|
SEC22B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.86270002042488E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.79709963261155E-10 |
| Normal-vs-Stage2 |
1.432970E-01 |
| Normal-vs-Stage3 |
2.321200E-01 |
| Normal-vs-Stage4 |
4.023900E-02 |
| Stage1-vs-Stage2 |
7.901900E-02 |
| Stage1-vs-Stage3 |
4.012100E-02 |
| Stage1-vs-Stage4 |
7.992600E-01 |
| Stage2-vs-Stage3 |
9.272400E-01 |
| Stage2-vs-Stage4 |
3.216200E-01 |
| Stage3-vs-Stage4 |
3.685600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.06660000118464E-08 |
| Normal-vs-AfricanAmerican |
2.66199999998662E-06 |
| Normal-vs-Asian |
7.312400E-01 |
| Caucasian-vs-AfricanAmerican |
4.400000E-01 |
| Caucasian-vs-Asian |
4.241400E-01 |
| AfricanAmerican-vs-Asian |
3.075200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.40290018385758E-11 |
| Normal-vs-Female |
8.180400E-02 |
| Male-vs-Female |
4.444900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.563300E-04 |
| Normal-vs-Extreme_Weight |
6.84919998494848E-09 |
| Normal-vs-Obese |
2.181000E-04 |
| Normal-vs-Extreme_Obese |
7.656100E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.850600E-01 |
| Normal_Weight-vs-Obese |
7.756800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.702000E-01 |
| Extreme_Weight-vs-Obese |
2.577400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.460800E-01 |
| Obese-vs-Extreme_Obese |
8.957000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.825200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.76096999999764E-05 |
| Normal-vs-Age(61-80Yrs) |
7.07189995452495E-09 |
| Normal-vs-Age(81-100Yrs) |
8.991900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.846200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.485830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.404760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.903220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.614600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.36144437337771E-12 |
| Normal-VS-Type2 PRCC |
1.353630E-02 |
| Normal-VS-KIRP CIMP |
9.036000E-01 |
| Normal-VS-Unclassified PRCC |
8.207900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.319710E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.217980E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.843620E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.854600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.445400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.963600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.24079999999938E-05 |
| Normal-vs-N1 |
6.411600E-01 |
| Normal-vs-N2 |
7.118800E-01 |
| N0-vs-N1 |
8.715900E-02 |
| N0-vs-N2 |
5.218400E-01 |
| N1-vs-N2 |
7.890600E-01 |
|
|
